Computer alerts may boost life-saving prescriptions for kidney patients

NCT ID NCT07605390

Not yet recruiting Knowledge-focused Sponsor: Baylor Research Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 2 times

Summary

This study tests whether a simple electronic alert in the medical record system can help doctors prescribe guideline-recommended medications for adults with type 2 diabetes and kidney disease. About 600 patients will be randomly assigned to have their doctor receive an alert or not. The goal is to see if the alert increases use of drugs that protect the heart and kidneys.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Epic-based clinician notification (electronic health record alert)
What this could lead to: If successful, this could show that simple electronic alerts help doctors follow guidelines and prescribe more effective medications for patients with diabetes and kidney disease.
What could go wrong: This is a pragmatic trial testing a notification system, not a new drug. The alert may not change prescribing habits, and results may not apply to other healthcare systems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Albuminuria chronic kidney disease chronic renal failure syndrome type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASE TYPE 2 DIABETES

Contacts and locations

Locations

Baylor Scott and White Health

Dallas, Texas, 75246, United States
Baylor Scott and White, Advanced Heart Care

Plano, Texas, 75093, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.